John K. Clarke

John K. Clarke

Director/Board Member chez ATYR PHARMA, INC.

Fortune : 38 010 $ au 29/02/2024

70 ans
Health Technology
Technology Services
Producer Manufacturing

Profil

John K.
Clarke
Managing Partner ohn Clarke has a 35 year record of early-stage venture capital investment success.
John co-founded Cardinal Partners in 1997 and currently serves as a Managing Partner of the firm.
John leads Cardinal’s life sciences investment efforts and has had an extraordinary record of success.
John led the firm’s investment in Cubist Pharmaceuticals (Nasdaq:CBST), Momenta Pharmaceuticals (Nasdaq:MNTA), Alnylam Pharmaceuticals (Nasdaq:ALNY), Sirtris Pharmaceuticals (Nasdaq:SIRT) and Verastem (Nasdaq:VSTM).
John also spearheaded Cardinal’s investment in and served as a director for: TechRx Corporation (acquired by NDCHealth) and Visicu (Nasdaq:EICU – acquired by Phillips Electronics).
John currently serves on the Board of Directors for Cardinal portfolio companies Abide Therapeutics, aTyr Pharma, Ivenix , and Vividion Therapeutics, as well as Alnylam Pharmaceuticals.
John entered the venture industry in 1982 with DSV Partners, a pioneer venture capital fund formed in 1968.
John led DSV’s health care and life sciences efforts, and was a co-founder and served as interim CEO of numerous successful companies including Alkermes (Nasdaq:ALKS), Arris Pharmaceuticals (Nasdaq:ARRS), DNX (Nasdaq:DNXX) and Cubist Pharmaceuticals (Nasdaq:CBST).
As a managing partner at DSV in that firm’s latter years, John led the firm’s evolution into Cardinal Partners.
John has served on the National Venture Capital Association’s Board of Directors where he was Chairman of its Regulatory Committee and Membership Committee.
John was a founding director of the Greater Philadelphia Venture Group as well as its past President and Chairman.
John received his B.A.
in Economics and Biology from Harvard University and his M.B.A.
from the Wharton School at the University of Pennsylvania.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
17/05/2023 19 797 ( 0,03% ) 38 010 $ 29/02/2024

Postes actifs de John K. Clarke

SociétésPosteDébut
ATYR PHARMA, INC. Director/Board Member 14/03/2024
Founder 01/01/1997
Director/Board Member -
Director/Board Member -
Hands Together Director/Board Member -
Tous les postes actifs de John K. Clarke

Anciens postes connus de John K. Clarke

SociétésPosteFin
ALNYLAM PHARMACEUTICALS, INC. Founder 10/01/2019
MOMENTA PHARMACEUTICALS, INC. Director/Board Member 31/12/2015
Director/Board Member 06/06/2008
Chief Executive Officer -
░░░ ░░░░░░░░ ░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Voir l'expérience en détail de John K. Clarke

Formation de John K. Clarke

Harvard University Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de John K. Clarke

Relations

100 +

Relations au 1er degré

30

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées4
GE AEROSPACE

Producer Manufacturing

ATYR PHARMA, INC.

Health Technology

ALNYLAM PHARMACEUTICALS, INC.

Health Technology

VERASTEM, INC.

Health Technology

Entreprise privées24

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Finance

Technology Services

Arris Pharmaceuticals Corp.

Health Technology

Health Technology

Commercial Services

Hands Together

Producer Manufacturing

Greater Philadelphia Venture Group

Commercial Services

Technology Services

Techrx Technology Services Corp.

Rib X Pharmaceuticals, Inc.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. John K. Clarke